Health11 months ago
Late-Breaking Results of a Preclinical Efficacy Study Presented at ENDO 2023 Show Seraxis SRE Sustainably Reverses Type-1-Diabetes Hyperglycemia
GERMANTOWN, Md. (Newswire.com) –Ā Seraxis today announced late-breaking resultsĀ of an ongoing study evaluating the efficacy of SRE pancreatic clusters in a type 1 diabetes model at the...